Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Intraventricular Glioblastoma.

Garcia CR, Villamar MF, Villano JL.

Neurohospitalist. 2019 Oct;9(4):239-240. doi: 10.1177/1941874418817950. Epub 2018 Dec 30. No abstract available.

PMID:
31534616
2.

Intraventricular glioblastoma multiforme: Case report.

Sarikafa Y, Akçakaya MO, Sarikafa S, Ozkaya F, Akdemir O, Celik SE.

Neurocirugia (Astur). 2015 May-Jun;26(3):147-50. doi: 10.1016/j.neucir.2014.09.001. Epub 2015 Feb 10.

PMID:
25677169
3.
4.

Intraventricular Epithelioid Glioblastoma: A Case Report.

Nitta N, Moritani S, Fukami T, Yoshimura Y, Hirai H, Nozaki K.

World Neurosurg. 2018 Apr;112:257-263. doi: 10.1016/j.wneu.2018.01.200. Epub 2018 Feb 6. Erratum in: World Neurosurg. 2019 Feb;122:727.

PMID:
29425978
5.

Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.

Weller M, Müller B, Koch R, Bamberg M, Krauseneck P; Neuro-Oncology Working Group of the German Cancer Society.

J Clin Oncol. 2003 Sep 1;21(17):3276-84.

PMID:
12947063
6.

Transplantable canine glioma model for use in experimental neuro-oncology.

Salcman M, Scott EW, Schepp RS, Knipp HC, Broadwell RD.

Neurosurgery. 1982 Sep;11(3):372-81.

PMID:
6290929
7.

Neuro-oncology: Proteomic profiling could facilitate glioblastoma diagnosis.

Malkki H.

Nat Rev Neurol. 2014 Sep;10(9):484. doi: 10.1038/nrneurol.2014.142. Epub 2014 Aug 5. No abstract available.

PMID:
25092416
8.

In Silico Neuro-Oncology: Brownian Motion-Based Mathematical Treatment as a Potential Platform for Modeling the Infiltration of Glioma Cells into Normal Brain Tissue.

Antonopoulos M, Stamatakos G.

Cancer Inform. 2015 Aug 10;14(Suppl 4):33-40. doi: 10.4137/CIN.S19341. eCollection 2015. Review.

10.

STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.

Thota B, Arimappamagan A, Kandavel T, Shastry AH, Pandey P, Chandramouli BA, Hegde AS, Kondaiah P, Santosh V.

J Neurosurg. 2014 Aug;121(2):374-83. doi: 10.3171/2014.4.JNS131198. Epub 2014 May 30.

PMID:
24878287
11.

Neuro-oncology practices in Australia: a Cooperative Group for Neuro-Oncology patterns of care study.

Chen JY, Hovey E, Rosenthal M, Livingstone A, Simes J.

Asia Pac J Clin Oncol. 2014 Jun;10(2):162-7. doi: 10.1111/ajco.12079. Epub 2013 May 29.

PMID:
23714694
12.

Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.

Clark PA, Bhattacharya S, Elmayan A, Darjatmoko SR, Thuro BA, Yan MB, van Ginkel PR, Polans AS, Kuo JS.

J Neurosurg. 2017 May;126(5):1448-1460. doi: 10.3171/2016.1.JNS152077. Epub 2016 Jul 15.

13.

Drug review: Safety and efficacy of bevacizumab for glioblastoma and other brain tumors.

Narita Y.

Jpn J Clin Oncol. 2013 Jun;43(6):587-95. doi: 10.1093/jjco/hyt051. Epub 2013 Apr 12. Review.

PMID:
23585688
14.

Pseudoprogression in a Patient With Glioblastoma Presenting as a Neurosurgical Emergency.

Sayeed WM, Easaw JC, Singh AD.

Can J Neurol Sci. 2015 Sep;42(5):347-9. doi: 10.1017/cjn.2015.53. Epub 2015 Jul 29. No abstract available.

PMID:
26219577
15.
16.

Personalized medicine in neuro-oncology.

Levin VA.

CNS Oncol. 2016;5(2):55-8. doi: 10.2217/cns-2016-0006. Epub 2016 Mar 21. No abstract available.

17.

Intratumoral delivery of bortezomib: impact on survival in an intracranial glioma tumor model.

Wang W, Cho HY, Rosenstein-Sisson R, Marín Ramos NI, Price R, Hurth K, Schönthal AH, Hofman FM, Chen TC.

J Neurosurg. 2018 Mar;128(3):695-700. doi: 10.3171/2016.11.JNS161212. Epub 2017 Apr 14.

PMID:
28409734
18.

Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.

van Tellingen O, Yetkin-Arik B, de Gooijer MC, Wesseling P, Wurdinger T, de Vries HE.

Drug Resist Updat. 2015 Mar;19:1-12. doi: 10.1016/j.drup.2015.02.002. Epub 2015 Mar 6. Review.

PMID:
25791797
19.

Treatment and survival of glioblastoma patients in Denmark: The Danish Neuro-Oncology Registry 2009-2014.

Hansen S, Rasmussen BK, Laursen RJ, Kosteljanetz M, Schultz H, Nørgård BM, Guldberg R, Gradel KO.

J Neurooncol. 2018 Sep;139(2):479-489. doi: 10.1007/s11060-018-2892-7. Epub 2018 May 12.

PMID:
29754199
20.

Supplemental Content

Support Center